Bold people will build the next generation of space and our university partners are a critical source of creativity and emerging technology
Bold people will build the next generation of space and our university partners are a critical source of creativity and emerging technology
Pair will main event in Abu Dhabi in a rematch six years in the making
The Justice Department revealed charges this week against a Texas man who allegedly stormed the U.S. Capitol on Jan. 6 and threatened on social media to kill U.S. Democratic Representative Alexandria Ocasio-Cortez. Prosecutors asked a judge on Friday to keep the man, Garret Miller, in jail ahead of a court appearance, according to court records. Images of social media posts allegedly authored by Miller, which appear to announce his trip to the Capitol and threaten the life of Ocasio-Cortez as well as a Capitol Police officer, are cited in the court filing.
Morgan Stanley has rocketed in recent months. Best of all, it still has a cheap valuation relative to its peers and impressive growth prospects.
The U.S. Centers for Disease Control and Prevention said it had administered 20,537,990 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 41,411,550 doses. The tally of vaccine doses are for both Moderna and Pfizer/BioNTech vaccines as of 6:00 a.m. ET on Saturday, the agency said. A total of 2,437,670 vaccine doses have been administered in long-term care facilities, the agency said.
Youssef En-Nesyri scored his second hat-trick in four games on Saturday as Sevilla dispatched Cadiz 3-0 to move up to third in La Liga.
As students head back into the classroom for the new school year, education experts want the lockdown experiences of 2020 to provide learning opportunities.
NEW YORK, Jan. 23, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of QuantumScape Corporation (NYSE: QS) between November 27, 2020 and December 31, 2020, inclusive (the “Class Period”) of the important March 8, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for QuantumScape investors under the federal securities laws. To join the QuantumScape class action, go to http://www.rosenlegal.com/cases-register-2017.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email email@example.com or firstname.lastname@example.org for information on the class action. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) QuantumScape’s purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) QuantumScape’s battery technology was not sufficient for electric vehicle performance as it would not be able to withstand the aggressive automotive environment; (3) QuantumScape’s battery technology likely provided no meaningful improvement over existing battery technology; (4) QuantumScape is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles (5) the successful commercialization of QuantumScape’s battery technology was subject to much more significant risks and uncertainties than defendants had disclosed; and (6) as a result of the foregoing, defendants materially overstated the value and prospects of QuantumScape’s battery technology. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 8, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-2017.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at email@example.com or firstname.lastname@example.org. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 email@example.com firstname.lastname@example.org email@example.com www.rosenlegal.com
Illegal streaming sites pop up across Facebook, Reddit and Twitter in build-up to fight
Holders Arsenal were knocked out of the FA Cup at Southampton, watched by their new sub Mat Ryan, while Man City survived a scare in a 3-1 win at Cheltenham.
Larry King, US broadcaster and talk show legend, has died at age 87 after a battle with coronavirus.
Fans will be hoping for an improvement on their previous showing as Manchester United and Liverpool face off for the second time in eight days. A dismal 0-0 draw was played out at Anfield in the Premier League, but this time a home tie in the FA Cup fifth round against either West Ham is up for grabs. Jurgen Klopp will be keen to advance and get his side back to winning ways following a surprise slump in form, while Ole Gunnar Solskjaer will see the game as another chance to show his team are progressing into one capable of challenging for honours this season.
Manchester City will be looking to avoid an FA Cup upset today as Pep Guardiola takes his side to face League Two Cheltenham Town. Cheltenham’s reward for beating Morecambe in the third round is a plum tie against one of England’s top teams - and City must be on their guard at Whaddon Road. Michael Duff’s Robins are sitting sixth in League Two heading into this clash, which, in all honesty, is a free hit for the minnows considering the firepower Guardiola will be able to call on.
The FTC has issued its first-ever fines using the BOTS Act, a law targeting ticket scalper bots.
A lottery player in America has become an overnight billionaire, holding the winning ticket for a jackpot worth more than $US1 billion.
Veteran Morne Steyn and rookie Stravino Jacobs starred as the Bulls reached the South African Currie Cup final Saturday with a 26-21 victory over the Lions in Pretoria.
Zenith Lab’s Vision 20 Reviews – Is the best supplement to treat your vision naturally? Find more about ingredients, side effects and capsules much more… Vision 20 [Updated 2021] – Is Ryan Shelton’s Vision 20 Supplement Really effective? Vision 20 Reviews by Nuvectramedical Zenith Lab’s Vision 20 Reviews – Is the best supplement to treat your vision naturally? Find more about ingredients, side effects and capsules much more… McHenry, IL, Jan. 23, 2021 (GLOBE NEWSWIRE) -- What is Vision 20 Dietary Supplement? Vision 20 dietary supplement targets the real culprit of vision loss. These are the reactive oxygenated species that are harmful toxins that damage the eye cells. Already Planned to Order? Click Here to Buy Vision 20 Supplement Dr. Ryan Shelton, the director of Zenith Labs and the creator of Vision 20 supplement has developed a product that kills and eliminates the real cause of vision loss and ultimately strengthens your eye health, giving you good and healthy eyesight even as you grow older. Age related factors start to emerge when you reach 40 years and above and a common problem is vision loss or decreasing quality of vision. This is why you mostly see people who are of old age wear eyeglasses or hear them complain about not seeing well. Vision impairment is a very common problem but if you use the right Vision 20 supplement to counter these problems, you can enjoy 20-20 vision as you grow older and doing simple tasks like driving, reading, writing, knitting and other activities will not be hard anymore. In today’s times, technology has also been one of the main causes of vision loss because of the blue light radiation that is emitted by screens and monitors whether it is from your television, tablet, PC or phones. Some young people are now struggling with poor eyesight because of these screens and monitors. But Zenith Labs found a way to prevent eye strains and problems by protecting your eyesight. Vision 20 is made from extensive studies and tests to ensure its high effectiveness and safety. It is a revolutionary product that is the perfect solution to restore a 20-20 eyesight. How does Vision 20 work? Vision 20 works best by eliminating the harmful toxic substance, the reactive oxygenated species and blue light radiation in our eyes. Vision 20 protects your eyes from the blue light emitted by our gadgets and prevents eye strain. Vision 20 helps the eyes to focus by repairing our eye lenses and by supporting flexibility when we shift our focus from object to object. Vision 20 contains nutrients that can aid our eyes adjustments whenever we focus from one subject to another. The Vision 20 supplement contains the sufficient amount of nutrients and minerals that allows the eyes to concentrate its repairing of our near or far distance and low light vision capabilities. It actively repairs the eyes for you to regain your 20-20 vision. The formula of Vision 20 uses a rich number of carotenoids which is a chemical compound that can fully protect the human eyes. Upon discovering this compound, Dr. Ryan Shelton switched its focus on gathering the ingredients that contain this compound and started developing a revolutionary formula that contains a potent number of carotenoids while ensuring the safety of the user taking the product. Read Full List of Vision 20 Ingredients and Side Effects Before You Buy What are the ingredients used in Vision 20? After a long and extensive research, trials and tests, Vision 20 was made. Using only organic ingredients to create a formula that allows the body to easily absorb the nutrients inside the capsule and then naturally starts the effects of the Vision 20 supplement working in repairing and protecting the user’s vision. To fully understand the Vision 20 supplement, it is best to learn more about what makes it an amazing product and that is by studying the ingredients it uses. Here are some of the ingredients added in creating the Vision 20 supplement: Rose Hips (100mg) Rose hips are added because they contain the chemical compound lycopene which gives a shield to your eye lenses and helps eliminate the ROS toxic substances trying to destroy your vision. Vitamin A (2,100mcg) Composed of retinyl palmitate and 71% beta-carotene. Vitamin A is very essential to keep the eyes healthy and can also boost low light vision. Vitamin A can prevent you from having infections in the eyes and inflammation as well. Bilberry Fruit Extract (100mg) Known to boost low light vision and also very important in supporting good eye health because it contains a good amount of nutrients to keep supplying the eyes with sufficient oxygen and minerals. Grape Seed Extract (25mg) A good ingredient that counters age related eye problems from occurring in your eyes. Protecting its health and vision against degrading quality of vision or deteriorating functions. Taurine (50mg) Contains a rich amount of amino-acid that rejuvenates the eye health and prevents it from suffering glaucoma and cataract. It also decreases the eye blood pressure and strains. Zinc Citrate (20mg) With a concentrated amount of zinc in a human body, it is easy for the system to absorb more carotenoids from the meals we eat. Therefore, with more carotenoids in our body, our eyes are well protected. Other ingredients added are lycopene, zeaxanthin from a marigold flower extract,lutein which is also from a marigold flower extract, rice flour, gelatin, magnesium stearate and silica. All of the ingredients added in Vision 20 are carefully measured in perfect amounts to ensure each dosage holds a potent number of nutrients, vitamins and minerals for the Vision 20 supplement to effectively work. Moreover, it is important to acknowledge how pure and organic the formula Zenith Labs have used in Vision 20 supplement because the product is GMO-free which means there are no dangerous fillers or additives that are added in the formula. The product is completely safe to take with 0 side effects. Vision 20 is manufactured in the USA in a facility that also follows GMP guidelines. It is important to note that the product is not made to be a cure or medication of any ailment or disease. Vision 20 is manufactured mainly to become a good Vision 20 supplement that restores perfect vision and protects it from common eye problems. What is the recommended dose of Vision 20? To achieve the optimal effects that is promised by Vision 20, it is recommended to take 1 capsule a day regularly. Vision 20 is advisable to drink at least 1 glass of water while taking the capsule to help it easily get digested and to let the body quickly distribute the nutrients to the eyes. However, if you are pregnant, have medical conditions or allergic to any of the ingredients used in creating Vision 20, it is highly advised to go see your physician first and show him or her a bottle of Vision 20 to check if you are permitted to take the Vision 20 supplement or not. Although the Vision 20 supplement is safe to take, your condition may trigger unwanted effects to your body or to the child you are carrying. Lowest Price Guaranteed – Get Vision 20 Supplement for The Most Discounted Price Online Advantages of Vision 20 Supplement Vision 20 gives people who have vision problems the chance to regain that 20-20 vision they once had. Reading, driving or doing simple things become easier when you have good vision. You don’t have to slow and delay yourself from doing easy things because it’s hard to read or see them because with the help of Vision 20, you have good and crystal-clear eyesight again. To go into specifics, here are the major benefits you will enjoy: The Vision 20 supplement can give you 20-20 vision. This is because the supplement actively repairs and restores the health of your eyes. It eliminates the main causes of what’s destroying your vision and repairs the damages these have made. Vision 20 then restores a healthy and perfect vision to the user of the supplement. Eyesight booster. Nutrients carried by Vision 20 supplement supports the boosting of your near, far and low light visions which helps you do your simple tasks without a challenge because reading and seeing things are not as hard anymore. Improve blood circulation and provide sufficient energy to the eyes. Having the steady flow of blood and oxygen to the supply can help it function better and Vision 20 ensures its formula to do this. How much does the Vision 20 supplement cost? To be able to purchase Vision 20 supplement, you can visit their official website and grab a bottle there. Zenith Labs offers big discounts to customers who choose their 3 or 6 bottle packages. The more bottles you buy, the bigger discounts you’ll enjoy. One bottle of Vision 20 contains 30 capsules which is a good supply for 1 whole month. The price for 1 bottle is only $49. If you buy the 3-bottle package, the price per bottle becomes $39 and $33 per bottle for the 6-bottle package. Considering the product is high in demand, it is recommended to stock up and have extra bottles ready in case you run out because the supply of the product does not meet the high demands by the market. Who should not use Vision 20? If you are under 18 or pregnant, you better avoid taking dietary supplements generally! It is always a good idea to consult your doctor before taking any supplement. FDA and Supplements: The FDA will never approve a dietary supplement. According to the Food and Drug Administration, dietary supplements are a category of their own, and they are not subject to FDA regulation or approval. If a company is claiming that the FDA approves their diet supplement, run. This is a clear misrepresentation. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Conclusion – Is Vision 20 Supplement worth your money? Vision 20 is definitely worth your money. Since age related problems are commonly vision loss, it would be best to protect your vision and use a safe supplement with no side effects to avoid additional problems, right? Vision 20 is an organic yet powerful supplement that can help you boost your vision while helping you regain that 20-20 eyesight while protecting it against infections and inflammation. Vision 20 dietary supplement offers the ultimate package that supports both eye health and its functions. Visit the Official Vision 20 Here for Huge Discount Pricing Media Contact: Zenith Labs 4610 Prime Parkway McHenry, IL, 60050, USA Email: firstname.lastname@example.org Phone: +1 (800) 928-1184 This product review is for informational purposes only. The information does not constitute advice or an offer to buy. Any purchase made from this story is made at your own risk. Consult an expert advisor/health professional before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website selling the product. The content on this release does not take any responsibility directly or indirectly. Contact Nuvectramedical at email@example.com This news has been published for the above source. Nuvectramedical [ID=16596] KISS PR PRODUCT REVIEWER COMPENSATION DISCLOSURE Pursuant to the Federal Trade Commission's guidance of the public in conducting its affairs in conformity with legal requirements comprised in 16 C.F.R. § 255 et seq. on the use of endorsements and testimonials in advertising, this Product Reviewer Compensation Disclosure is provided by KissPR.com LLC and its affiliated entities (hereinafter referred to collectively as “KISS PR”). This disclosure applies to content displayed on all mobile, desktop, and other online versions of KISS PR’s websites and to those of KISS PR’s distribution partners (hereinafter referred to collectively as “the Websites”) and is provided for the purpose of disclosing the nature of the connection between KISS PR and product reviewers, advertisers, sponsors, endorsers, and other third-parties whose advertisements, sponsorships, endorsements, testimonials, opinions, or other product-related or service-related statements or reviews may appear on the Websites (hereinafter referred to as an "Product Reviewer"). This Product Reviewer Compensation Disclosure is intended to disclose to you that in consideration of payment of monetary and other compensation from a Product Reviewer, as described below, KISS PR sells various advertising, sponsorships, and marketing campaigns that are featured on one or more of the Websites. There is a financial connection related to some of the products or services mentioned, reviewed, or recommended on the Websites between KISS PR and the Product Reviewer that owns, markets, or sells such product or service. If you decide to purchase a product or service featured on one or more of the Websites, KISS PR will not receive compensation related to that purchase from a Product Reviewer but may receive a one-time fee from the Product Reviewer for posting or distributing the product review on or via the Websites. Further, KISS PR may post or otherwise promote on the Websites content, including editorial content, which may feature third-party products and services (a "Reviewed Product"). This content may contain weblinks to third-party owned or operated web sites where you can purchase Reviewed Product (“Product Link”). If you click on a Product Link and then purchase a Reviewed Product on the linked web site, KISS PR will not receive compensation from the third-party offering the Reviewed Product (the “Vendor”). Weblinks on the Websites featuring a Reviewed Product may be added to posts or articles that are not identified on the Websites as comprising or containing paid or sponsored content. In such case, a disclosure statement about the Reviewed Product and the compensation that KISS PR might receive in connection with its purchase by you will be included in such posts or articles. Further, third-party advertisements may be posted on the Websites. Each time you click on such an advertisement, KISS PR may receive compensation from the third-party advertiser, even if you do not purchase any product or service from that third-party. KISS PR will, subject to the disclaimer of liability set forth below, endeavor to ensure that product or service endorsements appearing in the Websites or in posts or articles distributed via the Websites reflect the honest opinions, findings, beliefs, or experiences of the Product Reviewer as they relate to such product or service. If you have any complaint, concern, or question relating to the content of any such post or article, including alleged infringement of any intellectual property rights, you should address your complaint, concern, or question directly to the Product Reviewer or the Vendor. NO REPRESENTATIONS OR WARRANTIES; NON-RELIANCE. EXCEPT FOR ANY EXPRESS REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS DISCLOSURE STATEMENT, NEITHER KISS PR NOR ANY OTHER PERSON ON KISS PR’S BEHALF HAS MADE OR MAKES ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY, EITHER ORAL OR WRITTEN, WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE, TRADE, OR OTHERWISE, ALL OF WHICH ARE EXPRESSLY DISCLAIMED, AND YOU ACKNOWLEDGE THAT YOU HAVE NOT RELIED UPON ANY REPRESENTATION OR WARRANTY MADE BY KISS PR OR ANY OTHER PERSON ON KISS PR’S BEHALF, EXCEPT AS SPECIFICALLY PROVIDED IN THIS DISCLOSURE STATEMENT. DISCLAIMER OF LIABILITY. IN NO EVENT SHALL KISS PR BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OF OR THE ACCURACY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY ADVERTISEMENT, SPONSORSHIP, ENDORSEMENT, TESTIMONIAL, OPINION, OR OTHER PRODUCT-RELATED OR SERVICE-RELATED STATEMENT OR REVIEW APPEARING IN THE WEBSITES OR IN ANY POST OR ARTICLE DISTRIBUTED VIA THE WEBSITES. © 2021 KissPR.com LLC Media Contact Website: [KISS PR Brand Story PressWire] - Email: Media@kisspr.com Attachment Vision 20 [Updated 2021] – Is Ryan Shelton’s Vision 20 Supplement Really effective? Vision 20 Reviews by Nuvectramedical
Ole Gunnar Solskjaer is hoping his Manchester United squad can take heart from his own FA Cup heroics against Liverpool back in 1999 as the two sides meet at Old Trafford on Sunday. United meet Liverpool for the second time in seven days after securing a goalless Premier League draw at Anfield last weekend. The Red Devils went on to win 2-1 at Fulham in midweek to retake top spot in the table, while Liverpool are six points off the pace following Thursday night's shock 1-0 home loss to Burnley.
Larry King, whose interviews with world leaders, movie stars and ordinary individuals helped define American conversation for half a century, died Saturday. (Jan. 23)
(Bloomberg) -- Governor Andrew Cuomo said more vaccines are on the way for New York, though he said the bigger challenge is getting skeptical Black and Latino residents to take the shot. Fatalities in the U.S. dropped below 4,000 for the first time in three days.California reported a 30% drop in new Covid-19 cases compared with the state’s 14-day rolling average. Dr. Deborah Birx, who served as coordinator of the Trump administration’s Coronavirus Task Force, she “always” considered quitting her White House role as efforts to contain the pandemic became increasingly politicized. A doctors’ group in the U.K. has urged the government to review the 12 weeks allowed for people to receive a second dose of the vaccine produced by Pfizer Inc. and BioNTech SE. The manufacturer suggests 21 days. Meanwhile, France’s top health authority recommends doubling that three-week gap as a way to stretch supplies and speed inoculations.Key Developments:Global Tracker: Cases exceed 98.3 million; deaths pass 2.1 millionVaccine Tracker: More than 60.3 million shots given worldwideTo revive Manhattan, Wall Street offers help with vaccinationsBiden’s 100-day vaccine goal was nearly met before he arrivedHong Kong has imposed its first Covid lockdown in KowloonWhy the mutated coronavirus variants are so worrisome: QuickTakeSubscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click CVID on the terminal for global data on cases and deaths.New California Cases Tumble Below Average (2:15 p.m. NY)California reported a 30% drop in the number of new Covid-19 cases yesterday compared with the state’s 14-day rolling average, while the number of deaths edged up. California added 22,972 new cases versus the state’s 14-day rolling average of 33,126. Deaths climbed by 593, above the 503 average, to 36,361, according to the health department’s website. The state’s 14-day positivity rate was 10%, its best showing in a month. California has administered almost 40 million tests in total.Uruguay, Chile Set to Begin Vaccinations (2:10 p.m. NY)Uruguay has signed its first vaccine deals with Pfizer Inc.-BioNTech SE and Sinovac Biotech Ltd. as the spread of coronavirus in the small South American nation gathers pace.The government will purchase 2 million doses from Pfizer and 1.75 million from Sinovac, with delivery scheduled for March, President Luis Lacalle Pou said in a news conference on Saturday.Chile will take delivery of 4 million shots from Sinovac next week, allowing the country to begin mass vaccination of its 18-million population, said President Sebastian Pinera. Half the doses will arrive on Jan. 28 and the other half on Jan. 31, Pinera said in a televised address late Friday.Birx Says Inaugural Security Could Prove Superspreader Event (1:59 p.m. NY) Dr. Deborah Birx, who served as coordinator of the Trump administration’s Coronavirus Task Force, warned in an interview set to air Sunday that events surrounding Wednesday’s inaugural proceedings could prove to be a so-called superspreader event.“Right now in the District of Columbia, there are National Guard troops here from every state in the union, probably, young individuals who are most likely to have asymptomatic infection if they do get infected,” Birx said in a preview of an exchange with Margaret Brennan on CBS News’ “Face The Nation.” “And they’re congruently living and eating maskless, 25 to 30,000 of them from all over the United States.”Birx, an internationally recognized AIDS researcher and former U.S. Army physician, said in the same interview that she “always” considered quitting her White House role as efforts to contain the pandemic became increasingly politicized.Sweden Weighs Norway Travel Ban (1:06 p.m. NY)Sweden will likely introduce a ban on travel from Norway after the government there imposed strict measures around Oslo to suppress the spread of a more contagious variant of the virus. Dagens Industri reports that the Swedish Interior Minister Mikael Damberg is working on a ban, and a decision will be made shortly.Doctors Seek U.K. Review of Shot Delay (12:21 p.m. NY)The British Medical Association said the U.K. should “urgently review” its decision allowing a second dose of the Pfizer-BioNTech coronavirus vaccine as much as 12 weeks after the first, instead of the shorter gap recommended, the Associated Press reported.The doctors’ group said there was growing concern in the medical profession about the delay, noting that no other nation has adopted the U.K.’s approach, the AP said, citing a statement.The U.K. has administered 5.38 million first doses of vaccines overall and 467,000 second doses through Jan. 21, according to its Covid dashboard. Prime Minister Boris Johnson said Friday that a new variant of the virus that has emerged in the country may be deadlier than initially thought.Italy’s Conte Attacks Pfizer, AstraZeneca for Vaccine Delays (12:08 p.m. NY)Italian Prime Minister Giuseppe Conte said that delays in vaccine consignments by Pfizer Inc and AstraZeneca Plc are “unacceptable,” renewing threats of legal action against the drug makers that so far have found little traction among European peers. In a Facebook post on Saturday, Conte said the companies are breaching their contracts with “direct impact on the life and health of citizens.”Italy’s vaccination campaign, which had been one of Europe’s fastest, slowed down after a 29% decline in vial consignments of Pfizer vaccine this week. From next week, the company will further reduce deliveries in light of the fact that each vial is used for six doses rather than five. AstraZeneca, whose vaccine is set for approval by the EU’s medicine agency on Jan. 29, confirmed that it will be able to deliver 3.4 million doses to Italy in the first quarter, less than half of the 8 million originally planned, according to Conte’s statement.Italy is set to ease restrictions for Milan and the surrounding Lombardy region from Sunday, after new data submitted by the local government showed that the country’s financial capital had been classified as “high risk” by mistake. Milan will move to the so-called orange level, the second of Italy’s three-tier system of virus curbs. Shops will reopen but restaurants, bars and gyms will remain closed.U.K. Hospitalizations Drop for Third Day (11:14 a.m. NY)People being treated for Covid-19 in U.K. hospitals fell for a third day, to 37,899 on Jan. 21. Another 33,552 positive cases were reported on Saturday, about 5,000 below the average over the previous seven days. Deaths were above the weekly average at 1,348. More than 5.86 million people have received a first dose of vaccine.Cuomo Seeks to Overcome Vaccine Skepticism (11:10 a.m. NY)A day after saying New York was running out vaccines, Governor Andrew Cuomo said the coming week’s supply has begun to arrive from the federal government -- and he encouraged hesitant minorities to take it.“Our bigger problem is the acceptance, especially among the Black and the Latino community,” Cuomo said on Saturday at a vaccine center in Brooklyn. “Why? Because they are skeptical. They are skeptical of a vaccine approved by the Trump administration.” He said New York had done its own reviews and that the vaccines are safe.The state reported 13,786 new cases, continuing a trend of lower infections since hitting a record of almost 20,000 on Jan. 14. The statewide positive test rate dipped slightly to 5.26%, as did hospitalizations to 8,802. Another 144 people died.Portugal Reports Record Cases, Deaths (10:15 a.m. NY)Portugal on Saturday reported 15,333 new cases of Covid-19, surpassing the previous daily record announced Wednesday and bringing the country’s total to 624,469. The government also reported a record 274 daily fatalities, bringing the total 10,194. The number of patients in intensive-care units rose by five to 720. The country’s national health service has a capacity of about 1,200 intensive-care beds.While confinement measures are in place, travel will be allowed on Sunday for voting in the presidential election. In Portugal, the president is mainly a figurehead and policy is set by the prime minister and his government.Bolsonaro Drops in Polls Amid Pandemic Toll (10 a.m. NY)Brazilian President Jair Bolsonaro’s approval rating dropped the most since he took office in 2018, weighed down by the pandemic’s death toll and confusion surrounding a national vaccination plan.Bolsonaro, who scoffed at masks and echoed baseless theories about the virus voiced by former U.S. President Donald Trump, polled 26% in an Ideia survey for Exame published Friday, compared with 37% last week. His popularity fell to 37% in a Datafolha poll from 31% in December.Germany Sees 3 Million Vaccine Doses in Feb. (9:20 a.m. NY)German Health Minister Jens Spahn said he expects 3 million vaccine doses to be delivered to the country in February, despite production problems by AstraZeneca Plc. “Unfortunately, this will be less than expected”, Spahn told the Sunday edition of the tabloid Bild. He re-affirmed his pledge that all German citizens will be offered a vaccine by the end of summer.Broadcaster Larry King Dies (8:20 a.m. NY)Larry King, the broadcast interviewer who became the star of a top-rated U.S. cable talk show, has died at age 87 in Los Angeles, according to a statement on his Twitter account. The cause of death wasn’t provided, but he had recently undergone treatment for Covid-19.LSE Chief Proposes Lifeline for Firms: Sky (8:19 a.m. NY)David Schwimmer, chief executive of the London Stock Exchange Group, is leading discussions to create a fund that would invest in companies hit hard by the coronavirus, Sky News reported. The fund’s size would initially be 300 million pounds ($411 million), though that could be increased to as much as 1 billion pounds.Mauritius Gets 100,000 Doses of Astra Shot (7:47 a.m. NY)Mauritius will use its first 100,000 Covid-19 vaccines to inoculate 50,000 front-line workers as part of a plan the government said will contribute to a revival of crucial industries. The shots, which are being produced under license from AstraZeneca Plc, are a donation from the Indian government.While Mauritius has just 28 active cases, according to a statement from the health ministry on Jan. 18, the country’s economy is heavily dependent on a return of tourists from places where the virus is far more widespread.France Mulls Extending Dosage Interval (7:09 a.m. NY)France’s top health authority is recommending a doubling of the time between the two required Covid-19 vaccine shots as a way to stretch supplies and inoculate as many people as possible. Giving the second injection six weeks after the initial one would allow at least 700,000 more people to be protected during the first month. The French advice follows guidance two days ago by the U.S. Centers for Disease Control and Prevention that said follow-up doses could be given up to six weeks later if it’s not feasible to get them in the recommended interval.Parts of Sweden Halt Moderna Vaccine (6:57 p.m. HK)Several regions in Sweden will temporarily stop using the Moderna vaccine, after a shipment was delivered below the recommended storage temperature, Radio Sweden reported. Around 1,000 shots already had been administered. Authorities don’t think there’s a risk of side effects, but will be monitoring to ensure the medicine triggers an immune response.Swedish PM Admits Strategy Fell Short (6:56 p.m. HK)Swedish Prime Minister Stefan Lofven said his government should have taken more aggressive steps and moved more quickly to stop the spread of the pandemic, and he takes full responsibility for the initial strategy that led the country to suffer a disproportionately high number of deaths.In an interview with Dagens Nyheter, Lofven said the government’s response to the spread of the virus among the elderly was inadequate, and that testing should have begun earlier.“As prime minister, I take full responsibility for the strategy that we have,” Lofven said.France Aims for 15 Million Inoculations by June (6:20 p.m. HK)France is sticking to a goal of inoculating 15 million people by June, despite hiccups with the roll-out of vaccines, French Industry Minister Agnes Pannier-Runacher said Saturday in an interview on France Inter radio.“I am reasonably confident that we will surpass this target,” she said. “We aren’t experiencing delays in deliveries of Pfizer dosages.”The EU is facing fewer deliveries from Pfizer Inc. and German partner BioNTech SE after the companies said they needed to modify a factory in Belgium. Another supplier, AstraZeneca Plc, on Friday said deliveries to the EU of its vaccine will initially be slower than expected due to lower production at a manufacturing site. France passed the threshold of 3 million Covid-19 cases on Friday.Norway Locks Down Oslo (5:27 p.m. HK)Norway is imposing the strictest measures since March 12 in the area around the capital in an attempt to suppress infections of the more contagious coronavirus variant.All shops, cinemas, restaurants and churches will be closed and the service of alcohol banned until Jan. 31, Health Minister Bent Hoie announced in a webcast speech on Saturday. Amateur sports and leisure activities won’t be allowed.South Africa Backs Distribution of Astra Shots (4:36 p.m. HK)South Africa’s regulator granted the health department permission to distribute the vaccine from AstraZeneca Plc and the University of Oxford in its first nod for Covid-19 inoculations.The National Department of Health has been recognized by the South African Health Products Regulatory Authority as a supplier of The Serum Institute of India Ltd., Health Minister Zweli Mkhize said in a statement late Friday.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Pep Guardiola’s side travel to Whaddon Road looking to advance to the fifth round